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Background: The plant-derived estrogen biochanin A is known to cause vasodila-
tion, but its mechanism of action in hypertension remains unclear. This study was
undertaken to investigate the effects and mechanisms of biochanin A on the
thoracic aorta in two-kidney, one clip (2K1C) renovascular hypertensive rats.
Methods: Hypertension was induced by clipping the left renal artery, and control
age-matched rats were sham treated. Thoracic aortae were mounted in tissue baths
to measure isometric tension.
Results: Biochanin A caused concentration-dependent relaxation in aortic rings from
2K1C hypertensive and sham-treated rats, which was greater in 2K1C rats than in sham
rats. Biochanin A-induced relaxation was signiﬁcantly attenuated by removing the
endothelium in aortic rings from 2K1C rats, but not in sham rats. Nω-Nitro-L-arginine
methyl ester, a nitric oxide synthase inhibitor, or indomethacin, a cyclooxygenase
inhibitor, did not affect the biochanin A-induced relaxation in aortic rings from 2K1C
and sham rats. By contrast, treatment with glibenclamide, a selective inhibitor of
adenosine triphosphate-sensitive Kþ channels, or tetraethylammonium, an inhibitor of
Ca2þ-activated Kþ channels, signiﬁcantly reduced biochanin A-induced relaxation
in aortic rings from both groups. However, 4-aminopyridine, a selective inhibitor of
voltage-dependent Kþ channels, inhibited the relaxation induced by biochanin A in
2K1C rats, whereas no signiﬁcant differences were observed in sham rats.
Conclusion: These results suggest that the enhanced relaxation caused by biochanin A
in aortic rings from hypertensive rats is endothelium dependent. Vascular smooth
muscle Kþ channels may be involved in biochanin A-induced relaxation in aortae from
hypertensive and normotensive rats. In addition, an endothelium-derived activation of
voltage-dependent Kþ channels contributes, at least in part, to the relaxant effect of
biochanin A in renovascular hypertension.
& 2014. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).n Society of Nephrology. Publi
c-nd/4.0/).
logy, College of Medicine,
-Gu, Gwangju 501-759,
).Introduction
Estrogen replacement therapy markedly reduces the risk of
cardiovascular disease in postmenopausal women [1,2]. However,
the use of hormone replacement therapy as a cardioprotectiveshed by Elsevier. This is an open access article under the CC BY-NC-ND
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and feminizing effects in men. Phytoestrogens are naturally
occurring plant-derived nonsteroidal estrogens, which also bind
to the estrogen receptor, acting as estrogen agonists or antagonists
[3,4].
It has been shown that dietary soy-derived estrogens are
vasoactive and have beneﬁcial cardiovascular effects [5]. Both
dietary estrogens [6] and estradiol replacement therapy [7]
enhance the vasorelaxant response to acetylcholine in female
monkeys, whereas systemic arterial compliance was improved by
a red clover diet in menopausal women [8]. Biochanin A that
naturally occurs in soybeans and clover is estrogen-like [9]. It has
been shown to relax the rabbit basilar artery [10] and to induce
signiﬁcant sex-independent relaxation of rabbit coronary arteries
[11]. Furthermore, Wang et al [1] subsequently conﬁrmed that
biochanin A induces endothelium-independent relaxation in rat
aortic rings, of which mechanism involves blockage of Ca2þ entry
through the cell membrane and activation of Kþ channels. In
addition, biochanin A-induced vasorelaxation was increased in
spontaneously hypertensive rats than in normotensive rats, which
was mediated by the release of endothelium-derived substances
that may open voltage-dependent and Ca2þ-activated Kþ chan-
nels in the vascular smoothmuscle [12]. Under these backgrounds,
we have previously shown that an activation of Ca2þ-activated Kþ
channels in vasorelaxation is altered in two-kidney, one clip (2K1C)
renal hypertension [13]. Although an endothelium-derived activa-
tion of smooth muscle cell Kþ channels, which contributes to
biochanin A-induced vasorelaxation, was observed in sponta-
neously hypertensive rats, the effect of biochanin A on vascular
function in 2K1C renovascular hypertension remains unclear.
The present study was designed to examine the mechanisms
of the relaxing effects induced by biochanin A in the thoracic
aorta isolated from 2K1C renovascular hypertensive rats.Methods
Induction of 2K1C renovascular hypertension
Renovascular hypertension was induced in rats following the
2K1C Goldblatt model [14]. Brieﬂy, male Sprague–Dawley rats
(Samtako Inc., Osan, Korea), weighing 160–180 g, were anesthe-
tized with an intraperitoneal injection of sodium thiopental
(40 mg/kg). Under antiseptic conditions, an incision was made
on the left ﬂank to access the left renal artery, which was
separated from the renal vein and cleaned of connective tissue.
A U-shaped solid silver clip with an internal diameter of 0.2 mm
was applied to the exposed renal artery, resulting in the partial
occlusion of renal perfusion. The contralateral kidney remained
untouched, and the wound was closed. A group of age-matched
rats were sham treated and served as the control group. The
control animals underwent an operation similar to the 2K1C rats
except that no clip was used. All animals were fed normal chow
and were given tap water. They were used for the experiments at
10 weeks after the clipping, because endothelial dysfunction is
associated with the duration of hypertension [15]. Hypertensive
rats were selected based on their systolic blood pressure measured
in a conscious state by the tail cuff method.
Tissue preparation
The thoracic aorta between the aortic arch and diaphragmwas
carefully removed and placed in cold, standard physiological saltsolution with the following composition: NaCl 118.3mM, KCl
4.7mM, NaHCO3 25mM, MgCl2 1.2mM, KH2PO4 1.2mM, CaCl2
2.5mM, and glucose 11.1mM. Vessels were cleaned of adherent
fat and connective tissue, and then cut into 2–3mm long
cylindrical rings under a dissecting microscope. The rings were
suspended between two triangle-shaped stainless steel holders in
the vessel lumen in organ baths containing 15mL physiological
salt solution maintained at 3770.051C, aerated with a mixture of
95% O2 and 5% CO2, and maintained at a pH of 7.470.01. One of
the holders was ﬁxed at the bottom of the chamber, and the other
was connected to a Grass force displacement transducer (FTO3,
Quincey, MA, USA) to measure isometric tension development.
Prior to initiating speciﬁc experimental protocols, the aortic rings
were stretched to the point of their optimal length–tension
relationship 2 g, which was determined in similar preliminary
experiments using repeated exposure to 60mM KCl (obtained by
equimolar replacement of NaCl by KCl in the physiological
solution), and equilibration for a period of at least 90 minutes.
Protocols
At the beginning of the experiment, aortic rings were
stimulated with 60mM KCl to test their functional integrity.
In all experiments, aortic rings from 2K1C and sham-operated
rats were precontracted to 50% effective concentration (EC50)
with phenylephrine (3 107M in sham and 4108M in
2K1C), which were obtained in preliminary experiments.
When the contractile response achieved a steady state, relaxa-
tion–response curves to the cumulative addition of biochanin
A (from 107M to 104M), acetylcholine (from 109M to
105M), or sodium nitroprusside (SNP; from 1010M to
106.5M) were determined. In an alternate set of experiments,
the aorta was pretreated for 10 minutes with biochanin A
(3105M) prior to the addition of phenylephrine in the case
of acetylcholine- and SNP-induced relaxation. To verify the
role of functional endothelium in the vascular relaxant effects
of biochanin A, the endothelium was removed from some
thoracic aortae by gently rubbing the intimal surface with a
moistened cotton swab. The successful removal of the
endothelial cells from aortic rings was conﬁrmed via the
inability of acetylcholine to induce relaxation.
In another experiments, the nitric oxide synthase (NOS)
inhibitor Nω-nitro-L-arginine methyl ester (L-NAME, 104M) or
the cyclo-oxygenase inhibitor indomethacin (105M), and Kþ
channel blockers glibenclamide (3106M), tetraethylammo-
nium (TEA, 103M), or 4-aminopyridine (103M), were added
to the bath 10 minutes prior to the addition of phenylephrine.
Drugs
Acetylcholine, 4-aminopyridine, biochanin A, glibencla-
mide, indomethacin, L-NAME, SNP, and TEA were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). All other
chemicals were of analytical grade. Biochanin A, glibencla-
mide, and indomethacin were dissolved in dimethylsulfoxide,
and the others were prepared in distilled water. The ﬁnal
concentrations of dimethylsulfoxide were o0.05%, which did
not alter the contraction or relaxation responses.
Statistical analysis
The values presented in the ﬁgures are the means and
standard errors of the means. Relaxant responses are presented
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tension. The concentration causing half-maximal relaxation
(IC50) was determined by plotting the percentage of responses
and expressed as the mean of negative log molar (pD2)
for individual tissue response, using the Origin software
(Northampton, MA, USA). Statistical comparisons were per-
formed using Student t test or analysis of variance followed by
Duncan’s test for multiple comparisons. A P valueo0.05 was
considered statistically signiﬁcant.Biochanin A (−log M)
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Figure 2. Biochanin A-induced vasorelaxation in phenylephrine-Results
The systolic blood pressure was 19075 mmHg (n¼44,
Po0.05) and 13774 mmHg (n¼40) in 2K1C hypertensive
and sham-clipped rats, respectively.
Vasorelaxant responses to biochanin A
The tension induced by phenylephrine was enhanced in
the aortic rings from 2K1C rats (1.4570.07 g, Po0.05) com-
pared with those from sham rats (1.1270.06 g). Biochanin A
completely relaxed the aortic rings from 2K1C and sham rats
when they were precontracted with phenylephrine. However,
the relaxation was augmented in the aortic rings from 2K1C
rats than in the rings from sham rats (pD2: 5.0570.08 vs.
4.6770.07, Po0.05). This effect was more pronounced at the
higher concentration of biochanin A (Fig. 1). Biochanin A-
induced relaxation was signiﬁcantly attenuated by the removal
of the endothelium in the aortic rings from 2K1C rats (pD2:
4.6970.06, Po0.05), whereas no signiﬁcant differences were
observed in rings from sham rats (Fig. 2).
Vasorelaxant responses to acetylcholine and SNP
Acetylcholine-induced vasodilation was signiﬁcantly attenu-
ated in the aortic rings from 2K1C rats than in those from sham
rats. Treatment with L-NAME (104M) completely blocked
the acetylcholine-induced vasodilatory effect in both 2K1CBiochanin A (−log M)
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Figure 1. Biochanin A-induced vasorelaxation in phenylephrine-
precontracted aortic rings from sham-clipped control and 2K1C
hypertensive rats. Points represent means7SE for the number (n) of
experiments in parentheses. nPo0.05, compared with sham values.
2K1C, two-kidney, one clip.
precontracted aortic rings without endothelium from sham-clipped
control (A) and 2K1C hypertensive rats (B). nPo0.05, compared with
corresponding control values. 2K1C, two-kidney, one clip; Endo,
without endothelium.and sham groups (data not shown). Biochanin A (3105M)
had no effect on acetylcholine-induced vasodilation in either
sham or 2K1C rats (Fig. 3). The vasorelaxation response to SNP
was not altered in 2K1C rats. Biochanin A did not affect SNP-
induced vasodilation (Fig. 4).
Effects of L-NAME and indomethacin on biochanin A-induced
vasorelaxation
Preincubation with L-NAME or indomethacin had no effect
on biochanin A (3105M)-induced vasodilation in either
sham or 2K1C rats (Fig. 5).
Effects of Kþ channel blockers on biochanin A-induced
vasorelaxation
Pretreatment with glibenclamide, an inhibitor of adenosine
triphosphate (ATP)-sensitive Kþ channels, and TEA, an inhibitor
of Ca2þ-activated Kþ channels, signiﬁcantly reduced biochanin A
(3105M)-induced relaxation in 2K1C and sham-clipped rats.
Figure 3. Effects of biochanin A on vasodilatory responses induced
by acetylcholine in aortic rings from sham-clipped control and 2K1C
hypertensive rats. nPo0.05, compared with corresponding sham
values. 2K1C, two-kidney, one clip; BCA, biochanin A.
Figure 4. Effects of biochanin A on vasodilatory responses induced
by sodium nitroprusside in aortic rings from sham-clipped control
and 2K1C hypertensive rats. 2K1C, two-kidney, one clip; BCA, biocha-
nin A; SNP, sodium nitroprusside.
Figure 5. Effects of Nω-nitro-L-arginine methyl ester and indo-
methacin on the relaxation induced by biochanin A in aortic rings
from sham-clipped control (A) and 2K1C hypertensive (B) rats. Data
are obtained from six to eight experiments. 2K1C, two-kidney, one clip;
IDM, indomethacin; L-NAME, Nω-nitro-L-arginine methyl ester.
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Kþ channels, inhibited biochanin A-induced relaxation only in
2K1C rats with no effects in sham rats (Fig. 6).Discussion
We previously conﬁrmed that vascular reactivity to con-
tractile agonist is enhanced in disease states such as hyper-
tension [16]. As shown in our previous ﬁndings, the contractile
response to phenylephrine was augmented in 2K1C hyperten-
sive rats than in sham-clipped normotensive rats. In the
present study, biochanin A induced dose-dependent relaxa-
tion in phenylephrine-precontracted aortic rings with intact
endothelium isolated from 2K1C and sham rats, of which themagnitude was augmented in hypertensive rats. The relaxant
effect of biochanin A in aortic rings from sham rats with or
without endothelium was comparable, suggesting that biocha-
nin A-induced relaxation is endothelium-independent and
may directly affect the vascular smooth muscle in normoten-
sive rats. Similar results have been demonstrated in rabbit
coronary [11] or basilar arteries [10] and in rat aortae [12].
However, as has been shown previously in genetically hyper-
tensive rats [12], the relaxant effect of biochanin A was
signiﬁcantly attenuated by the removal of the endothelium
in aortic rings from 2K1C hypertensive rats. These observa-
tions imply that the vasorelaxing effect of biochanin A is
partially endothelium dependent in hypertensive aortae,
whereas it is endothelium independent in sham rats.
Acetylcholine causes NO release via the activation of speciﬁc
endothelial receptors, resulting in the activation of endothelial
NOS [17]. The present study conﬁrmed earlier observations
[15,18] that endothelium-dependent relaxation to acetylcholine
is markedly depressed in 2K1C hypertensive rats compared
with that in sham-clipped control rats. Treatment with L-NAME
Figure 6. Effects of glibenclamide (A), tetraethylammonium (B), and
4-aminopyridine (C) on the relaxation induced by biochanin A in
aortic rings from sham-clipped control and 2K1C hypertensive rats.
Data are obtained from six to eight experiments. nPo0.05, compared
with corresponding control values. 2K1C, two-kidney, one clip.
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effect in both groups, suggesting that acetylcholine-induced
vasodilation is largely attributable to NOS-derived NO. Although
the relaxation induced by acetylcholine was attenuated inhypertensive rats, biochanin A did not affect acetylcholine-
induced endothelium-dependent vasorelaxation in either 2K1C
or sham rats. In addition, biochanin A had no effect on SNP (which
is an NO donor)-induced endothelium-independent vasodilation
in aortic rings from 2K1C and sham rats. These results indicate
that the functions of NO synthesis or NO-mediated relaxation in
aortic rings from hypertensive and normotensive rats are not
altered by biochanin A.
Although biochanin A did not affect acetylcholine-induced
vasorelaxation in 2K1C hypertensive and sham rats in our
experiments, in order to clarify whether the vasodilator NO is
involved in biochanin A-induced relaxation, the effects of L-
NAME on the relaxation induced by biochanin A were exam-
ined. L-NAME did not affect biochanin A-induced relaxation in
2K1C and sham rats. The results again imply that the role of
NO is not involved in biochanin A-induced relaxation in either
group. The results of the present study are in agreement with
previous data from the coronary artery11 and aorta,12 which
suggest that vasodilator NO is not a candidate contributor to
biochanin A-induced relaxation. Conversely, Torregrosa et al
[10] reported that biochanin A-induced relaxation is partially
reduced by L-NAME treatment, which indicates that the
relaxant effect of biochanin A in aortae with endothelium
from rabbits is due to the release of NO. One possible
explanation may be attributed to the differences in the
experimental conditions, species, or strains [12]. Alternatively,
the endothelial release of prostacyclins or endothelium-
derived hyperpolarizing factor (EDHF) other than NO may be
responsible [19]. In the present study, however, indomethacin,
an inhibitor of the synthesis of prostaglandins [20], had little
effect on biochanin A-induced relaxation in aortic rings from
2K1C and sham rats. Taken together, an involvement of an
EDHF, acting through Kþ channels to cause hyperpolarization
of vascular smooth muscle cells [21], may be raised. It has been
indeed known that the EDHF-mediated vasorelaxation was
preserved in an animal model of renovascular hypertension
[22,23].
The EDHF passes through the internal elastic lamina and
vascular smooth muscle, and causes an activation of ion
channels, thus initiating smooth muscle hyperpolarization
and inducing relaxation [24]. In the endothelium and smooth
muscle, Kþ channels control the vascular tone and arterial
blood pressure [25]. The activation of Kþ channels causes a
hyperpolarization of cell membranes in vascular smooth
muscle and thus inhibits Ca2þ inﬂux via voltage-gated Ca2þ
channels. Therefore, an activation of Kþ channels may play a
role in Ca2þ signaling and modulate the arterial tone [26].
There are several types of Kþ channels preserved in vascular
smooth muscle [27]. In the present study, to examine whether
the Kþ channels contribute to biochanin A-induced vasodila-
tion in vascular smooth muscle, we pretreated with the Kþ
channel blockers glibenclamide, TEA, and 4-aminopyridine in
endothelium-intact aortic rings from 2K1C hypertensive and
sham rats. Biochanin A-induced relaxation was signiﬁcantly
reduced by glibenclamide, a blocker of ATP-sensitive Kþ
channels, in 2K1C and sham rats. In addition, TEA, which
blocks large-conductance Ca2þ-activated Kþ channels when
used in appropriate concentrations [12], also inhibited the
relaxant effect of biochanin A in both groups. These results
imply that activation of both ATP-sensitive and Ca2þ-activated
Kþ channels may be involved in biochanin A-induced relaxation
in hypertensive and normotensive rats. Interestingly, 4-aminopyr-
idine, an inhibitor of voltage-dependent Kþ channels, signiﬁcantly
Kidney Res Clin Pract 33 (2014) 181–186186attenuated biochanin A-induced relaxation in aortic rings from
2K1C rats, but no signiﬁcant differences were observed in sham
rats. Therefore, the greater relaxation induced by biochanin A in
rings from 2K1C rats compared with those from sham rats in our
experiment, may in part be responsible for the voltage-dependent
Kþ channels and evoke hyperpolarization of the smooth muscle
cells. Similar results were also observed in genetically hyperten-
sive rats, in which the activation of Kþ channels contributes to the
vasorelaxation in hypertension [12]. In addition, a previous study
reported that TEA inhibits the vasorelaxant effect of biochanin A in
normotensive rats [12], whereas the effects of TEA on biochanin A-
induced relaxationwere comparable between 2K1C and sham rats
in this study. A possible discrepancy may be attributed to the
different animal species used in this study.
In summary, the relaxant effect of biochanin A is augmented
in aortae of 2K1C hypertensive rats compared with those of
sham-clipped control rats, and the relaxation is endothelium-
independent in sham rats, whereas it is both endothelium-
dependent and -independent in 2K1C rats. An activation of
vascular smooth muscle Kþ channels may be involved in
biochanin A-induced relaxation in both 2K1C and sham rats.
In addition, the enhanced relaxation by biochanin A in reno-
vascular hypertension is mediated by endothelium-derived
substances that may evoke an activation of voltage-dependent
Kþ channels in vascular smooth muscle.Conﬂict of interest
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